Core Viewpoint - Ningbo Meinuo Pharmaceutical Co., Ltd. announced that its stock has triggered the downward adjustment clause for the "Meinuo Convertible Bonds" as the closing price has been below 90% of the current conversion price for at least 15 out of the last 30 trading days [1] Group 1 - The current conversion price is set at 25.68 CNY per share, with the threshold for adjustment being 23.11 CNY per share [1] - The company held its 17th meeting of the 5th Board of Directors on the same day and decided not to adjust the conversion price this time [1] - The next period for triggering the conversion price adjustment clause will restart from October 20, 2025 [1] Group 2 - The "Meinuo Convertible Bonds" were issued in January 2021 with an initial conversion price of 37.47 CNY per share, which has been adjusted multiple times due to equity distribution [1] - Investors are advised to be aware of investment risks associated with this situation [1]
美诺华决定本次不向下修正“美诺转债”转股价格